| Title | Description | Host | Host Type | Outcomes |
|---|---|---|---|---|
| Production Type | Predominantly C. coli (98.3%). | Swine | Other | 1 |
| Enrofloxacin use | 50 mg, injected. Predominantly C. coli (98.3%). | Swine | Piglets | 2 |
| Chlortetracycline Use | Chlortetracycline Use (Finishing, C. coli) [400 g/ton]. | Swine | Grower-finisher | 1 |
| Oxytetracycline use | 400g/ton, in feed. Predominantly C. coli (98.3%). | Swine | Piglets | 1 |
| Tiamulin Use | Tiamulin Use (Finishers, C. coli) [35 g/ton]. | Swine | Grower-finisher | 2 |
| Production Type | Predominantly C. coli (99.8%), sampled at farrowing, nursery, and finishing. | Swine | Other | 9 |
| Tiamulin use | 35 g/ton, in feed. Predominantly C. coli (98.3%). | Swine | Piglets | 2 |
| Lincomycin use | 32 mg, in water. Predominantly C. coli (98.3%). | Swine | Piglets | 1 |
| Production Type | Predominantly C. coli (98.3%). | Swine | Carcass | 8 |
| Enrofloxacin use | 50 mg, injected. Predominantly C. coli (98.3%). | Swine | Sows | 2 |